P-118Tepotinib (MSC2156119J) monotherapy in patients with MET-positive advanced hepatocellular carcinoma with Child-Pugh Class A liver function who have failed sorafenib treatment: phase Ib/II trial
In: Annals of Oncology, 2015, vol. 26, p. iv34-iv34
Ajouter à la liste personnelle